Melanoma mortality rates fell in 2010s as new therapies took holdDecember 12, 2022MelanomaDermatologyOncology
Stage 3 melanoma attacked with immunotherapy and a virus-like particleNovember 28, 2022MelanomaOncology
Chronic stress, especially race related, may hasten cancer deathNovember 13, 2022Diversity in MedicineOncologyGenitourinary CancerLung CancerMelanomaMixed Topics
Third COVID booster benefits cancer patientsNovember 12, 2022COVID-19 UpdatesBreast CancerGenitourinary CancerLung CancerMelanomaMixed Topics
A cost-effective de-escalation strategy in advanced melanomaNovember 7, 2022MelanomaBusiness of MedicineDermatologyOncology
Reminder that COVID-19 and cancer can be a deadly comboOctober 20, 2022COVID-19 UpdatesOncologyMelanomaBreast Cancer
Despite benefits, extended-interval pembro uptake remains lowSeptember 28, 2022Lung CancerColon and RectalMelanomaGenitourinary Cancer
A farewell to arms? Drug approvals based on single-arm trials can be flawedSeptember 19, 2022OncologyMixed TopicsBreast CancerGenitourinary CancerLung CancerMelanomaRare Diseases
Time to cancer diagnoses in U.S. averages 5 monthsSeptember 15, 2022Breast CancerOncologyGenitourinary CancerLung CancerMelanoma
‘Smoking gun–level’ evidence found linking air pollution with lung cancerSeptember 14, 2022Lung CancerOncologyMelanoma
Overall survival dips with vitamin D deficiency in melanomaSeptember 12, 2022MelanomaDermatologyOncology
